Global Subcutaneous Biologics Market Opportunities and Forecast 2022-2028
Report Code: KNJ1211536 No. of Pages: 167 Category: Medical Devices
Publisher: Date of Publish:
Publisher: Date of Publish:
This report provides a comprehensive analysis of current global Subcutaneous Biologics market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Subcutaneous Biologics industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.
According to GRD Survey, the global Subcutaneous Biologics market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.
Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Subcutaneous Biologics Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Subcutaneous Biologics market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.
The Global Subcutaneous Biologics Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Subcutaneous Biologics industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions
Segmented by Type
Syringe
Wearable injector
Segmented by Application
Hospital pharmacies
Retail pharmacies
Drug stores
Online pharmacies
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Novartis AG
GlaxoSmithKline
Genentech Inc.
F. Hoffmann-La Roche AG
Eisai Inc.
Bristol-Myers Squibb
Biogen Idec
Bayer AG
Alnylam Pharmaceuticals
AbbVie Inc.
Abbott Laboratories
Table of Contents
1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Subcutaneous Biologics Market Status and Forecast (2017-2028)
1.3.2 Global Subcutaneous Biologics Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Subcutaneous Biologics Supply by Company
2.1 Global Subcutaneous Biologics Sales Volume by Company
2.2 Global Subcutaneous Biologics Sales Value by Company
2.3 Global Subcutaneous Biologics Price by Company
2.4 Subcutaneous Biologics Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Subcutaneous Biologics Market Status by Type
3.1 Subcutaneous Biologics Type Introduction
3.1.1 Syringe
3.1.2 Wearable injector
3.1.3 Automatic injector
3.1.4 Implants
3.2 Global Subcutaneous Biologics Market by Type
3.2.1 Global Subcutaneous Biologics Sales Volume by Type (2017-2022)
3.2.2 Global Subcutaneous Biologics Sales Value by Type (2017-2022)
3.2.3 Global Subcutaneous Biologics Price by Type (2017-2022)
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Subcutaneous Biologics Market Status by Application
4.1 Subcutaneous Biologics Segment by Application
4.1.1 Hospital pharmacies
4.1.2 Retail pharmacies
4.1.3 Drug stores
4.1.4 Online pharmacies
4.2 Global Subcutaneous Biologics Market by Application
4.2.1 Global Subcutaneous Biologics Sales Volume by Application (2017-2022)
4.2.2 Global Subcutaneous Biologics Sales Value by Application (2017-2022)
4.2.3 Global Subcutaneous Biologics Price by Application (2017-2022)
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Subcutaneous Biologics Market Status by Region
5.1 Global Subcutaneous Biologics Market by Region
5.1.1 Global Subcutaneous Biologics Sales Volume by Region
5.1.2 Global Subcutaneous Biologics Sales Value by Region
5.2 North America Subcutaneous Biologics Market Status
5.3 Europe Subcutaneous Biologics Market Status
5.4 Asia Pacific Subcutaneous Biologics Market Status
5.5 Central & South America Subcutaneous Biologics Market Status
5.6 Middle East & Africa Subcutaneous Biologics Market Status
6 North America Subcutaneous Biologics Market Status
6.1 North America Subcutaneous Biologics Market by Country
6.1.1 North America Subcutaneous Biologics Sales Volume by Country (2017-2022)
6.1.2 North America Subcutaneous Biologics Sales Value by Country (2017-2022)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Subcutaneous Biologics Market Status
7.1 Europe Subcutaneous Biologics Market by Country
7.1.1 Europe Subcutaneous Biologics Sales Volume by Country (2017-2022)
7.1.2 Europe Subcutaneous Biologics Sales Value by Country (2017-2022)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Subcutaneous Biologics Market Status
8.1 Asia Pacific Subcutaneous Biologics Market by Country
8.1.1 Asia Pacific Subcutaneous Biologics Sales Volume by Country (2017-2022)
8.1.2 Asia Pacific Subcutaneous Biologics Sales Value by Country (2017-2022)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Subcutaneous Biologics Market Status
9.1 Central & South America Subcutaneous Biologics Market by Country
9.1.1 Central & South America Subcutaneous Biologics Sales Volume by Country (2017-2022)
9.1.2 Central & South America Subcutaneous Biologics Sales Value by Country (2017-2022)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Subcutaneous Biologics Market Status
10.1 Middle East & Africa Subcutaneous Biologics Market by Country
10.1.1 Middle East & Africa Subcutaneous Biologics Sales Volume by Country (2017-2022)
10.1.2 Middle East & Africa Subcutaneous Biologics Sales Value by Country (2017-2022)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Subcutaneous Biologics Manufacturing Cost Analysis
11.5 Subcutaneous Biologics Sales Channel and Distributors Analysis
11.5.1 Subcutaneous Biologics Sales Channel
11.5.2 Subcutaneous Biologics Distributors
11.6 Subcutaneous Biologics Downstream Major Buyers
12 Global Subcutaneous Biologics Market Forecast by Type and by Application
12.1 Global Subcutaneous Biologics Sales Volume and Sales Value Forecast (2023-2028)
12.2 Global Subcutaneous Biologics Forecast by Type
12.2.1 Global Subcutaneous Biologics Sales Volume Forecast by Type
12.2.2 Global Subcutaneous Biologics Sales Value Forecast by Type
12.2.3 Global Subcutaneous Biologics Price Forecast by Type
12.3 Global Subcutaneous Biologics Forecast by Application
12.3.1 Global Subcutaneous Biologics Sales Volume Forecast by Application
12.3.2 Global Subcutaneous Biologics Sales Value Forecast by Application
12.3.3 Global Subcutaneous Biologics Price Forecast by Application
13 Global Subcutaneous Biologics Market Forecast by Region/Country
13.1 Global Subcutaneous Biologics Market Forecast by Region (2023-2028)
13.1.1 Global Subcutaneous Biologics Sales Volume Forecast by Region (2023-2028)
13.1.2 Global Subcutaneous Biologics Sales Value Forecast by Region (2023-2028)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Takeda Pharmaceuticals Ltd.
14.1.1 Company Information
14.1.2 Subcutaneous Biologics Product Introduction
14.1.3 Takeda Pharmaceuticals Ltd.
Subcutaneous Biologics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.1.4 SWOT Analysis
14.2 Pfizer Inc.
14.2.1 Company Information
14.2.2 Subcutaneous Biologics Product Introduction
14.2.3 Pfizer Inc.
Subcutaneous Biologics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.2.4 SWOT Analysis
14.3 Novartis AG
14.3.1 Company Information
14.3.2 Subcutaneous Biologics Product Introduction
14.3.3 Novartis AG
Subcutaneous Biologics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.3.4 SWOT Analysis
14.4 GlaxoSmithKline
14.4.1 Company Information
14.4.2 Subcutaneous Biologics Product Introduction
14.4.3 GlaxoSmithKline
Subcutaneous Biologics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.4.4 SWOT Analysis
14.5 Genentech Inc.
14.5.1 Company Information
14.5.2 Subcutaneous Biologics Product Introduction
14.5.3 Genentech Inc.
Subcutaneous Biologics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.5.4 SWOT Analysis
14.6 F. Hoffmann-La Roche AG
14.6.1 Company Information
14.6.2 Subcutaneous Biologics Product Introduction
14.6.3 F. Hoffmann-La Roche AG
Subcutaneous Biologics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.6.4 SWOT Analysis
14.7 Eisai Inc.
14.7.1 Company Information
14.7.2 Subcutaneous Biologics Product Introduction
14.7.3 Eisai Inc.
Subcutaneous Biologics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.7.4 SWOT Analysis
14.8 Bristol-Myers Squibb
14.8.1 Company Information
14.8.2 Subcutaneous Biologics Product Introduction
14.8.3 Bristol-Myers Squibb
Subcutaneous Biologics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.8.4 SWOT Analysis
14.9 Biogen Idec
14.9.1 Company Information
14.9.2 Subcutaneous Biologics Product Introduction
14.9.3 Biogen Idec
Subcutaneous Biologics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.9.4 SWOT Analysis
14.10 Bayer AG
14.10.1 Company Information
14.10.2 Subcutaneous Biologics Product Introduction
14.10.3 Bayer AG
Subcutaneous Biologics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
14.10.4 SWOT Analysis
14.11 Alnylam Pharmaceuticals
14.12 AbbVie Inc.
14.13 Abbott Laboratories
15 Conclusion
16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com